insights_auto
Outlook: 65.6% bullish·6.2% bearish
Go to analysischevron_right
LILY34:BVMF
Eli Lilly And Company BDR
R$200,40
arrow_upward
+0,12%(+0,25) 1D
1 ຕ.ລ., 17 ໂມງ 6 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$202,00
High
R$202,00
Low
R$197,76
Mkt. cap
1,08 ລ້ານລ້ານ
Avg. vol.
37,72 ພັນ
Volume
44,67 ພັນ
52-wk high
R$223,07
52-wk low
R$141,56
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
Open
R$202,00
High
R$202,00
Low
R$197,76
Mkt. cap
1,08 ລ້ານລ້ານ
Avg. vol.
37,72 ພັນ
Volume
44,67 ພັນ
52-wk high
R$223,07
52-wk low
R$141,56
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
News stories
From web sources and news partners
The Motley Fool
·
16 ນາທີກ່ອນ
Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?
Barron's
·
2 ຊົ່ວໂມງກ່ອນ
Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs
Benzinga
·
6 ຊົ່ວໂມງກ່ອນ
Why Is Foghorn Therapeutics Stock Tumbling Today? - Foghorn Therapeutics (NASDAQ:FHTX)
Trefis
·
6 ຊົ່ວໂມງກ່ອນ
What Is The Options Market Telling Us About Eli Lilly Stock?
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50 ພັນ
Founded1876
Headquartersອິນເດຍນາໂພລິສ, ອິນເດຍນາ, ສະຫະລັດ
SectorPharmaceutical industry
Websitelilly.com